Review
Copyright ©2014 Baishideng Publishing Group Inc.
World J Stem Cells. Sep 26, 2014; 6(4): 404-420
Published online Sep 26, 2014. doi: 10.4252/wjsc.v6.i4.404
Table 2 Ongoing clinical trials of embryonic stem cell-derived cell transplantation
Clinical Trials.govStart (yr)SponsorStatusTitleConditionInterventionRemarks
NCT013449932011Advanced cell technologyRecruitingSafety and tolerability of transplantation of MA09-hRPE cells in patients with advanced dry age related macular degenerationAdvanced dry age related macular degenerationSub-retinal transplantation of MA09-hRPEA Phase I/II, open-label, multi-center, prospective study in United States. MA09-hRPE cells are human embryonic stem cell derived retinal Pigmented epithelial cells.
NCT013450062011Advanced cell technologyRecruitingTransplantation of MA09-hRPE cells in patients with stargardt's macular dystrophyStargardt's macular dystrophySub-retinal transplantation of MA09-hRPEA Phase I/II, open-label, multi-center, prospective study in United States
NCT014698322011Advanced cell technologyRecruitingSafety and tolerability of transplantation of hESC-RPE cells in patients with stargardt's macular dystrophyStargardt's macular dystrophy; fundus flavimaculatus; juvenile macular dystrophySub-retinal transplantation of MA09-hRPEA PhaseI/II, open-label, multi-center, prospective study in the United States
NCT016255592012CHA Bio and diostechRecruitingSafety and tolerability of MA09-hRPE cells in patients with stargardt's macular dystrophyStargardt's macular dystrophySub-retinal transplantation of MA09-hRPEA Phase I, open-label, prospective study in Korea
NCT016748292012CHA Bio and diostechRecruitingSafety and tolerability of transplantation of MA09-hRPE cells in patients with advanced dry age-related macular degeneration (AMD)Dry age Related macular degenerationSub-retinal transplantation of MA09-hRPEA Phase I/IIa, open-label, single-center, prospective study in Korea
NCT016912612014PfizerNot yet recruitingImplantation of human embryonic stem cell derived retinal pigment epithelium in subjects with acute wet age related macular degeneration and recent rapid vision declineAge related macular degenerationImplantation of human embryonic stem cell derived retinal pigment epitheliumPhase 1, open-label, safety and feasibility study in United Kingdom. PF-05206388 is human embryonic stem cell derived retinal pigment epithelium living tissue equivalent.
NCT020579002013Assistance publique - hôpitaux de ParisRecruitingTransplantation of human embryonic stem cell-derived progenitors in severe heart failure (ESCORT)Ischemic heart diseaseHuman embryonic stem cell-derived CD15+ Isl-1+ progenitorsPhase 1, open-label, feasibility and safety study in France
NCT021221592014University of California, Los AngelesNot yet recruitingResearch with retinal cells derived from embryonic stem cells for myopic macular degenerationMyopic macular degenerationMA09-hRPE cellular therapyA Phase I/II, Open-label, prospective study to determine the safety and tolerability in United States